GrantsFeed
Grants & Funding

DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award

Grant· Defense Health Agency Contracting Activity - DHACA· US· updated 2026-07-27
Deadline
Closes 2026-09-30
View & apply on official source

Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Idea Award (TIA) supports new, innovative, high-risk, high-gain ideas aimed at amyotrophic lateral sclerosis (ALS) drug or therapy discovery. The studies supported by this award mechanism are expected to be hypothesis-driven and generate preliminary data for future avenues of therapeutic investigation. Distinctive Features: Potential impact and innovation are important features of the TIA. Applications may demonstrate the ability to achieve interpretable results in the absence of preliminary data supporting the hypothesis. While the inclusion of preliminary data is not prohibited, the strength of the application should rely on the approach.

Don't miss the next one like this

New research grants in US open all the time. Get a free weekly email with only the ones that match — nothing else.

Get matching Research grants by email →
Weekly digest of only what matches your filters. Unsubscribe anytime.

Want help winning this?

Enter your email and we'll send the official application link, deadlines and pointers right away — free. Want a hand? Tick the box and we'll introduce you to a vetted grant or bid writer. The intro's free, and you only pay if you choose to work with them.

Related opportunities

See all alternatives →

More grantsResearch · US

People also viewed

Other grants visitors looked at from Defense Health Agency Contracting Activity - DHACA.

Always confirm details on the official source before applying — see our methodology.

DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award · GrantsFeed